National Jewish Health – Improving Cardiovascular Outcomes: The Next Era of Prevention 2025 (Videos)

Advanced Preventive Cardiology, Lipid Management & Cardiometabolic Risk Reduction

Overview

National Jewish Health Improving Cardiovascular Outcomes: The Next Era of Prevention 2025 is a cutting-edge cardiovascular prevention program designed to provide healthcare professionals with the latest advances in preventive cardiology, lipidology, cardiometabolic medicine, inflammation science, genetics, and cardiovascular risk reduction.

Hosted at the Molly Blank Conference Center in Denver, Colorado, this educational activity brings together nationally recognized experts in preventive cardiology, lipid management, endocrinology, nephrology, and population health to discuss how modern cardiovascular prevention is rapidly evolving beyond traditional risk factor management.

The course emphasizes the transition from reactive cardiovascular care to proactive prevention strategies through advanced risk assessment, precision medicine, lifestyle intervention, and emerging lipid-lowering therapies. Participants will gain practical knowledge applicable to both primary and secondary prevention of cardiovascular disease.

Course Highlights

• Expert-led preventive cardiology lectures
• Advanced lipidology and cholesterol management updates
• Lipoprotein(a) and Apolipoprotein B education
• Cardiometabolic and cardiorenal disease prevention
• Genetics and polygenic risk score applications
• Inflammation and atherosclerosis management
• Women’s cardiovascular health updates
• Environmental cardiovascular risk assessment
• Precision cardiovascular medicine concepts
• Emerging lipid-lowering therapies

Learning Objectives

Upon completion of this activity, participants will be able to:

• Describe the role of advanced lipid biomarkers in cardiovascular risk assessment.
• Evaluate the impact of Lipoprotein(a) and Apolipoprotein B on cardiovascular outcomes.
• Apply current LDL-cholesterol treatment targets in clinical practice.
• Identify patients who may benefit from emerging lipid-lowering therapies.
• Integrate polygenic risk scores into cardiovascular prevention strategies.
• Recognize the role of inflammation in atherosclerotic cardiovascular disease.
• Assess cardiovascular risks associated with obesity, chronic kidney disease, and metabolic dysfunction.
• Incorporate reproductive and pregnancy-related cardiovascular risk factors into patient evaluations.
• Understand environmental contributors to cardiovascular disease.
• Develop multidisciplinary approaches to long-term cardiometabolic risk reduction.

Major Topics Covered

Lipid Management & Advanced Cholesterol Therapy

The course provides an in-depth review of contemporary lipid management, including:

Core Topics

• LDL-C treatment goals
• Standard LDL-lowering therapies
• Lipoprotein(a)
• Apolipoprotein B
• HDL-C interpretation
• Triglyceride management
• Fasting versus non-fasting lipid testing
• Residual cardiovascular risk

Emerging Therapies

• PCSK9 inhibitors
• RNA-based therapies
• Novel triglyceride-lowering agents
• Combination lipid therapy strategies
• Precision lipid management

Participants learn how modern lipidology is reshaping cardiovascular prevention and improving long-term outcomes.

Preventive Cardiology & Cardiovascular Risk Reduction

The program explores contemporary prevention strategies involving:

• Primary prevention
• Secondary prevention
• Risk stratification
• Population health initiatives
• Precision cardiovascular medicine
• Patient-centered prevention models

The course emphasizes proactive intervention before cardiovascular disease develops.

Lipoprotein(a) & Residual Cardiovascular Risk

A major focus is placed on the growing importance of Lipoprotein(a) [Lp(a)] as an independent cardiovascular risk factor.

Topics include:

• Clinical significance of elevated Lp(a)
• Screening recommendations
• Risk assessment strategies
• Future Lp(a)-lowering therapies
• Integration into preventive cardiology practice

Cardiometabolic & Cardiorenal Medicine

Modern cardiovascular disease is increasingly viewed through a unified cardiometabolic framework.

Topics include:

• Obesity-related cardiovascular disease
• Diabetes and vascular complications
• Chronic kidney disease and cardiovascular risk
• Cardiorenal-metabolic syndrome
• Integrated prevention strategies

The course highlights the importance of multidisciplinary care across cardiology, endocrinology, nephrology, and primary care.

Genetics & Precision Cardiovascular Medicine

The genetics-focused sessions explore:

• Polygenic risk scores
• Genetic cardiovascular risk assessment
• Personalized prevention models
• Precision cardiology applications
• Future directions in cardiovascular genomics

Participants learn how genetics may influence future cardiovascular prevention and treatment strategies.

Inflammation & Atherosclerosis

The course reviews the growing evidence linking inflammation and cardiovascular disease.

Topics include:

• Acute inflammation
• Chronic inflammation
• Atherosclerotic disease progression
• Residual inflammatory risk
• Anti-inflammatory therapeutic approaches

These sessions demonstrate how inflammation contributes to cardiovascular disease independently of cholesterol levels.

Women’s Cardiovascular Health

Specialized lectures focus on cardiovascular risk factors unique to women, including:

• Pregnancy-associated cardiovascular risk
• Hypertensive disorders of pregnancy
• Reproductive cardiovascular health
• Long-term consequences of pregnancy complications

The program emphasizes the importance of reproductive history in cardiovascular risk assessment.

Environmental Cardiovascular Medicine

A unique feature of this conference is its exploration of environmental influences on cardiovascular health.

Topics include:

• Air pollution
• Environmental noise exposure
• Climate-related cardiovascular stress
• Temperature extremes
• Population-level cardiovascular impacts

These sessions review emerging evidence linking environmental exposures with cardiovascular morbidity and mortality.

Lifestyle Medicine & Behavioral Intervention

The course strongly emphasizes evidence-based lifestyle modification strategies, including:

• Nutrition
• Exercise prescription
• Weight management
• Behavioral intervention
• Long-term adherence strategies

The focus remains on scientifically validated approaches to cardiovascular risk reduction.

Team-Based Preventive Cardiology

The conference promotes collaborative care involving:

• Cardiologists
• Primary care physicians
• Lipidologists
• Endocrinologists
• Nephrologists
• Dietitians
• Pharmacists
• Behavioral health specialists

This multidisciplinary approach is essential for effective long-term prevention.

Included Lectures

Lipidology & Risk Assessment

• Lipid Tests, LDL-C Equations, and Fasting
• Lower LDL-Cholesterol Goals: An Ever-Moving Target
• Standard LDL-C Lowering Therapies
• Lipoprotein(a): What to Know and Why It Matters
• Beyond LDL: Apolipoprotein B, Triglycerides & HDL-C
• Emerging Lipid-Lowering Therapies

Special Populations & Prevention

• Pregnancy and Reproductive Associated Risks
• Acute and Chronic Inflammation
• Genetics and Polygenic Risk Scores
• Cardiovascular, Kidney, and Metabolic Health Integration

Environmental Health

• Climate Crisis and Cardiovascular Health
• Air Pollution and Cardiovascular Disease
• Environmental Noise Exposure
• Temperature Extremes and Vascular Risk

Target Audience

This course is ideal for:

• Cardiologists
• Preventive Cardiologists
• Lipidologists
• Internal Medicine Physicians
• Endocrinologists
• Nephrologists
• Family Medicine Physicians
• Preventive Medicine Specialists
• Primary Care Physicians
• Advanced Practice Providers
• Cardiology Fellows and Residents

Why This Course Stands Out

✔ Comprehensive preventive cardiology curriculum

✔ Strong focus on Lipoprotein(a) and advanced lipidology

✔ Covers emerging PCSK9 and RNA-based therapies

✔ Integrates genetics and precision medicine

✔ Explores inflammation as a cardiovascular risk factor

✔ Includes women’s cardiovascular health updates

✔ Addresses environmental and lifestyle influences on heart disease

✔ Promotes multidisciplinary cardiometabolic care

✔ Evidence-based and clinically applicable

✔ Highly relevant for modern cardiovascular prevention practice